Northern Trust’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2
Closed -$18.8K 4445
2023
Q4
$18.8K Hold
2
﹤0.01% 4372
2023
Q3
$32.3K Hold
2
﹤0.01% 4252
2023
Q2
$77.7K Hold
2
﹤0.01% 4105
2023
Q1
$74.5K Hold
2
﹤0.01% 4158
2022
Q4
$125K Hold
2
﹤0.01% 4018
2022
Q3
$106K Hold
2
﹤0.01% 4096
2022
Q2
$105K Hold
2
﹤0.01% 4147
2022
Q1
$178K Hold
2
﹤0.01% 4170
2021
Q4
$103K Hold
2
﹤0.01% 4411
2021
Q3
$211K Hold
2
﹤0.01% 4152
2021
Q2
$278K Sell
2
-6
-75% -$984K ﹤0.01% 3984
2021
Q1
$1.45M Hold
8
﹤0.01% 3420
2020
Q4
$1.42M Hold
8
﹤0.01% 3359
2020
Q3
$1.14M Hold
8
﹤0.01% 3340
2020
Q2
$1.06M Buy
+8
New +$978K ﹤0.01% 3328
2020
Q1
Hold
0
3953

Other funds holding GNPX

Northern Trust's GNPX Position: Q1 2024 in Review

Northern Trust sold out of Genprex (GNPX) in Q1 2024, closing a stake of 2 shares — an estimated $18.8K sold.

Northern Trust first reported a position in GNPX in Q2 2020 and held it in 15 quarters. The position peaked at $1.45M in Q1 2021. 8 funds tracked by Wall St. Rank hold GNPX as of Q1 2024.

  • Northern Trust reported no remaining Genprex position as of Q1 2024 after selling out during the quarter.
  • Northern Trust sold 2 Genprex shares in Q1 2024, an estimated $18.8K.
  • Northern Trust first reported a position in Genprex in Q2 2020 and held it in 15 quarters.
  • Northern Trust's Genprex position peaked at $1.45M in Q1 2021.
  • 8 funds tracked by Wall St. Rank held Genprex as of Q1 2024.

Based on Northern Trust's 13F filing for Q1 2024, filed 14 May 2024.